Stay updated on PCSK9 Inhibition After Heart Transplantation Clinical Trial
Sign up to get notified when there's something new on the PCSK9 Inhibition After Heart Transplantation Clinical Trial page.
Latest updates to the PCSK9 Inhibition After Heart Transplantation Clinical Trial page
- Check3 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.3%
- Check10 days agoChange DetectedThe website has added a new study titled 'Cardiac Allograft Vasculopathy Inhibition with Alirocumab (CAVIAR)' with the status 'Active, not recruiting' and updated to revision v2.11.0, while removing a notice about delays and a previous study on PCSK9 Inhibition.SummaryDifference7%
- Check18 days agoChange DetectedClinicalTrials.gov is addressing delays in displaying study record information, and the site has been updated to version 2.10.5, replacing the previous version 2.10.3.SummaryDifference4%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.3%
- Check53 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements in the latest release.SummaryDifference0.3%
- Check75 days agoChange DetectedThe website has been updated to version 2.10.0, introducing new features for viewing and comparing study record versions.SummaryDifference6%
Stay in the know with updates to PCSK9 Inhibition After Heart Transplantation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PCSK9 Inhibition After Heart Transplantation Clinical Trial page.